MediPharm Labs Corp. (TSX:LABS)
0.0650
0.00 (0.00%)
Apr 10, 2026, 2:33 PM EST
MediPharm Labs Revenue
In the year 2025, MediPharm Labs had annual revenue of 45.12M CAD with 7.54% growth. MediPharm Labs had revenue of 11.06M in the quarter ending December 31, 2025, a decrease of -8.14%.
Revenue
45.12M
Revenue Growth
+7.54%
P/S Ratio
0.61
Revenue / Employee
355.31K
Employees
127
Market Cap
27.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.12M | 3.16M | 7.54% |
| Dec 31, 2024 | 41.96M | 8.90M | 26.92% |
| Dec 31, 2023 | 33.06M | 10.95M | 49.49% |
| Dec 31, 2022 | 22.12M | 406.00K | 1.87% |
| Dec 31, 2021 | 21.71M | -14.30M | -39.71% |
| Dec 31, 2020 | 36.01M | -93.24M | -72.14% |
| Dec 31, 2019 | 129.25M | 119.05M | 1,167.42% |
| Dec 31, 2018 | 10.20M | - | - |
| Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| iAnthus Capital Holdings | 196.87M |
| 1CM Inc. | 75.01M |
| Rubicon Organics | 59.45M |
| C21 Investments | 45.62M |
| Avicanna | 25.48M |
| Greenway Greenhouse Cannabis | 9.13M |
| Optimi Health | 193.60K |
MediPharm Labs News
- 12 days ago - MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue - GlobeNewsWire
- 16 days ago - MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO - GlobeNewsWire
- 3 months ago - MediPharm Labs to Enter New Market with Costa Rica Supply Agreement - GlobeNewsWire
- 4 months ago - Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience - GlobeNewsWire
- 4 months ago - MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns - GlobeNewsWire
- 4 months ago - MediPharm Labs Completes First Shipment to France - GlobeNewsWire
- 5 months ago - MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law - GlobeNewsWire